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Résumé en
anglais
Since 2010, colonizations/infections by Rasamsonia argillacea species complex,
previously known as Geosmithia argillacea, have been regularly reported in
literature. We reviewed all available cases focusing on pathogenesis and clinical
relevance. The number of cases may be underestimated, as these fungi are
frequently misidentified as Penicillium or Paecilomyces species. Major underlying
conditions that predispose for infections by the R. argillacea species complex
include cystic fibrosis (CF) and chronic granulomatous disease (CGD). While the
pathogenic role of the colonization of CF lungs is still under debate, these molds
are the causative agent of pneumonia and/or invasive infections in CGD patients.
Given their thermotolerance and their resistance to various antifungals, especially
the azole drugs, a special attention should be paid to the chronic colonization of
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